Circulation: Cardiovascular Imaging. 2008;1:87-88
doi: 10.1161/CIRCIMAGING.107.763474
Tissue Characterization of a Suspected Aortic Valve Fibroelastoma With Cardiac Magnetic Resonance Imaging
Cosima Jahnke, MD
;
Ashraf Hamdan, MD
;
Eckart Fleck, MD
and
Ingo Paetsch, MD
From the Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, Germany.
Correspondence to Cosima Jahnke, MD, Internal Medicine/Cardiology, German Heart Institute Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail jahnke{at}dhzb.de
Apreviously healthy 29-year-old woman complaining of atypical chest pain was referred to our hospital. No cardiovascular risk factors were present. Resting ECG demonstrated normal sinus rhythm, and an exercise ECG during full workload was inconspicuous. Routine transthoracic echocardiography revealed a small lesion protruding from the aortic side of the aortic valve (Figure 1, Data Supplement Movie I) that was suggestive of a primary cardiac valve tumor. In such a case, differential diagnosis consists of tumor, thrombus, or vegetation and usually relies on clinical presentation or localization of the structure alone. Consequently, cardiac magnetic resonance (CMR) imaging was attempted for tissue characterization.

View larger version (115K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1. A, Transthoracic echocardiography detected a small, globular mass (7x7 mm, arrow) attached to the right coronary cusp of the aortic valve (left: parasternal long-axis view; right: parasternal short-axis view). B, Similarly, CMR cine imaging demonstrated a hypointense mass (arrow) and was used for the assessment of its relative standstill period during the cardiac cycle (left: 3-chamber view; right: short-axis view of the aortic valve). LA indicates left atrium; LV, left ventricle; RA, right atrium; and RV, right ventricle.
|
|
On T1- and T2-weighted CMR images, a structure with homogeneous
signal intensity identical to fibrous valve tissue was detected;
fat suppression ruled out the presence of fatty lesion components
(
Figure 2). During dynamic, contrast-enhanced first-pass perfusion
imaging, no increase in signal intensity was noted (Data Supplement
Movie III), whereas on delayed-enhancement imaging, a distinct
signal intensity increase was documented (
Figure 2). Thus, the
findings of CMR tissue characterization of the lesion corroborated
the diagnosis of an aortic valve fibroelastoma.

View larger version (89K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2. Top: T1-weighted images without and with fat suppression (SPIR; spectral presaturation with inversion recovery) and T2-weighted images of the tumor (7x8 mm, arrow) with a signal intensity identical to fibrous valve tissue. Bottom: Contrast-enhanced first-pass perfusion imaging proved the absence of a signal intensity increase, and delayed-enhancement imaging (DE) clearly depicted the contrast uptake of the tumor (arrow). RV indicates right ventricle; RA, right atrium; and LA, left atrium.
|
|
Fibroelastoma is believed to be the most common primary tumor
of cardiac valves, though the reported incidence in autopsy
studies is rather low.
1 Most papillary fibroelastomas affect
the left-sided valves without any preference for sex or age.
Concomitant valvular dysfunction is distinctly uncommon.
2 Fibroelastomas
are easily detected on echocardiography but are difficult to
visualize with CMR: Their small size and rapid, extensive movement
render adequate CMR imaging extremely difficult, particularly
during spin-echo sequences that are needed for texture characterization.
Consequently, existing CMR reports generally describe a fibroelastoma
as a hypointense mobile mass on cine gradient imaging only.
In the present case, the high diagnostic image quality of all spin-echo sequences was achieved by freezing of cardiac and valve motion: The aortic valve rest period was determined from a cine sequence with a high temporal resolution (50 phases per cardiac cycle; Data Supplement Movie II). Subsequently, spin-echo data acquisition was restricted to the rest period duration, thereby achieving an almost complete motion freezing of the valve and its lesion. With this approach, a dedicated CMR protocol consisting of all essential components for comprehensive tissue characterization could be completed, ie, T1- and T2-weighted black-blood imaging, contrast-enhanced first-pass perfusion, and delayed-enhancement imaging (inversion delay 220 ms, trigger delay 560 ms, and heart rate 82 bpm).
Because the risk of thromboembolic events is
6% in asymptomatic patients with an incidental finding of fibroelastoma, surgical removal of the fibroelastoma is usually recommended3; however, our young patient declined to undergo surgical resection. Thus, anticoagulation therapy was advised, and echocardiographic control examinations at regular short-term intervals were scheduled.
 |
Disclosures
|
|---|
None.
 |
Footnotes
|
|---|
The online-only Data Supplement is available at http://circimaging.ahajournals.org/cgi/content/full/1/1/87/DC1.
 |
References
|
|---|
1. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: diagnosis and management.
Lancet Oncol. 2005; 6: 219–228.
[CrossRef][Medline]2. Sun JP, Asher CR, Yang XS, Cheng GG, Scalia GM, Massed AG, Griffin BP, Ratliff NB, Stewart WJ, Thomas JD. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001; 103: 2687–2693.[Abstract/Free Full Text]
3. Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol. 1997; 30: 784–790.[Abstract]